Chemokines

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 11, 2015, Pages e52-e56

  Van Der Vorst, Emiel P C ^a   Döring, Yvonne ^a,b   Weber, Christian ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

abdominal aortic aneurysm; atherosclerosis; cardiovascular disease; chemokines; cytokine; myocardial infarction; stem cells

Indexed keywords

BETA CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 19; INTERLEUKIN 1BETA; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; CHEMOKINE RECEPTOR;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; BONE MARROW PROGENITOR CELL; CARDIOVASCULAR DISEASE; ENDOTHELIUM CELL; HEART INFARCTION; LEUKOCYTE; MACROPHAGE; MUSCLE STEM CELL; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STEM CELL MOBILIZATION; ANIMAL; HUMAN; IMMUNOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; CHEMOKINES; HUMANS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 84944893031     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.115.306359     Document Type: Article

References (41)

1. Asare Y, Schmitt M, Bernhagen J, The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis. Thromb Haemost 2013 109 391 398. doi: 10.1160/TH12-11-0831
2. Bachelerie F, Ben-Baruch A, Burkhardt AM, International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. Pharmacol Rev 2013 66 1 79. doi: 10.1124/pr.113.007724
3. Zernecke A, Weber C, Chemokines in atherosclerosis: proceedings resumed. Arterioscler Thromb Vasc Biol 2014 34 742 750. doi: 10.1161/ATVBAHA.113.301655
4. Hansson GK, Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 1685 1695. doi: 10.1056/NEJMra043430
5. Lesnik P, Haskell CA, Charo IF, Decreased atherosclerosis in CX3CR1-/-mice reveals a role for fractalkine in atherogenesis. J Clin Invest 2003 111 333 340. doi: 10.1172/JCI15555
6. Teupser D, Pavlides S, Tan M, Gutierrez-Ramos JC, Kolbeck R, Breslow JL, Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root. Proc Natl Acad Sci USA 2004 101 17795 17800. doi: 10.1073/pnas.0408096101
7. Braunersreuther V, Zernecke A, Arnaud C, Liehn EA, Steffens S, Shagdarsuren E, Bidzhekov K, Burger F, Pelli G, Luckow B, Mach F, Weber C, Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2007 27 373 379. doi: 10.1161/01.ATV.0000253886.44609.ae
8. Combadière C, Potteaux S, Rodero M, Simon T, Pezard A, Esposito B, Merval R, Proudfoot A, Tedgui A, Mallat Z, Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008 117 1649 1657. doi: 10.1161/CIRCULATIONAHA.107.745091
9. Soehnlein O, Drechsler M, Döring Y, Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol Med 2013 5 471 481. doi: 10.1002/emmm.201201717
10. Poupel L, Boissonnas A, Hermand P, Dorgham K, Guyon E, Auvynet C, Charles FS, Lesnik P, Deterre P, Combadiere C, Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2013 33 2297 2305. doi: 10.1161/ATVBAHA.112.300930
11. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, Shagdarsuren E, Lira SA, Weissman IL, Weber C, Jung S, CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 2009 113 963 972. doi: 10.1182/blood-2008-07-170787
12. White GE, McNeill E, Channon KM, Greaves DR, Fractalkine promotes human monocyte survival via a reduction in oxidative stress. Arterioscler Thromb Vasc Biol 2014 34 2554 2562. doi: 10.1161/ATVBAHA.114.304717
13. van der Vorst EP, Döring Y, Weber C, MIF and CXCL12 in cardiovascular diseases: functional differences and similarities. Front Immunol 2015 6 373. doi: 10.3389/fimmu.2015.00373
14. Zernecke A, Schober A, Bot I, von Hundelshausen P, Liehn EA, Möpps B, Mericskay M, Gierschik P, Biessen EA, Weber C, SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res 2005 96 784 791. doi: 10.1161/01.RES.0000162100.52009.38
15. Zoll J, Fontaine V, Gourdy P, Barateau V, Vilar J, Leroyer A, Lopes-Kam I, Mallat Z, Arnal JF, Henry P, Tobelem G, Tedgui A, Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc Res 2008 77 471 480. doi: 10.1093/cvr/cvm034
16. Akhtar S, Gremse F, Kiessling F, Weber C, Schober A, CXCL12 promotes the stabilization of atherosclerotic lesions mediated by smooth muscle progenitor cells in Apoe-deficient mice. Arterioscler Thromb Vasc Biol 2013 33 679 686. doi: 10.1161/ATVBAHA.112.301162
17. Kobayashi K, Sato K, Kida T, Omori K, Hori M, Ozaki H, Murata T, Stromal cell-derived factor-1α/C-X-C chemokine receptor type 4 axis promotes endothelial cell barrier integrity via phosphoinositide 3-kinase and Rac1 activation. Arterioscler Thromb Vasc Biol 2014 34 1716 1722. doi: 10.1161/ATVBAHA.114.303890
18. de Jager SC, Bot I, Kraaijeveld AO, Korporaal SJ, Bot M, van Santbrink PJ, van Berkel TJ, Kuiper J, Biessen EA, Leukocyte-specific CCL3 deficiency inhibits atherosclerotic lesion development by affecting neutrophil accumulation. Arterioscler Thromb Vasc Biol 2013 33 e75 e83. doi: 10.1161/ATVBAHA.112.300857
19. Ellison S, Gabunia K, Kelemen SE, England RN, Scalia R, Richards JM, Orr AW, Orr W, Traylor JG Jr, Rogers T, Cornwell W, Berglund LM, Goncalves I, Gomez MF, Autieri MV, Attenuation of experimental atherosclerosis by interleukin-19. Arterioscler Thromb Vasc Biol 2013 33 2316 2324. doi: 10.1161/ATVBAHA.113.301521
20. Gao XM, Liu Y, White D, Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J Mol Cell Cardiol 2011 50 991 999. doi: 10.1016/j.yjmcc.2010.12.022
21. Tarzami ST, Miao W, Mani K, Lopez L, Factor SM, Berman JW, Kitsis RN, Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation 2003 108 2387 2392. doi: 10.1161/01.CIR.0000093192.72099.9A
22. Yu CM, Lai KW, Chen YX, Huang XR, Lan HY, Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury. J Histochem Cytochem 2003 51 625 631
23. Liehn EA, Kanzler I, Konschalla S, Kroh A, Simsekyilmaz S, Sönmez TT, Bucala R, Bernhagen J, Weber C, Compartmentalized protective and detrimental effects of endogenous macrophage migration-inhibitory factor mediated by CXCR2 in a mouse model of myocardial ischemia/reperfusion. Arterioscler Thromb Vasc Biol 2013 33 2180 2186. doi: 10.1161/ATVBAHA.113.301633
24. Hu X, Dai S, Wu WJ, Tan W, Zhu X, Mu J, Guo Y, Bolli R, Rokosh G, Stromal cell derived factor-1 alpha confers protection against myocardial ischemia/reperfusion injury: role of the cardiac stromal cell derived factor-1 alpha CXCR4 axis. Circulation 2007 116 654 663. doi: 10.1161/CIRCULATIONAHA.106.672451
25. Lin HH, Chen YH, Chang PF, Lee YT, Yet SF, Chau LY, Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J Mol Cell Cardiol 2008 45 44 55. doi: 10.1016/j.yjmcc.2008.04.011
26. Lin HH, Chen YH, Chiang MT, Huang PL, Chau LY, Activator protein-2α mediates carbon monoxide-induced stromal cell-derived factor-1α expression and vascularization in ischemic heart. Arterioscler Thromb Vasc Biol 2013 33 785 794. doi: 10.1161/ATVBAHA.112.301143
27. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R, Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002 105 2974 2980
28. Noels H, Zhou B, Tilstam PV, Deficiency of endothelial CXCR4 reduces reendothelialization and enhances neointimal hyperplasia after vascular injury in atherosclerosis-prone mice. Arterioscler Thromb Vasc Biol 2014 34 1209 1220. doi: 10.1161/ATVBAHA.113.302878
29. Grudzinska MK, Kurzejamska E, Bojakowski K, Soin J, Lehmann MH, Reinecke H, Murry CE, Soderberg-Naucler C, Religa P, Monocyte chemoattractant protein 1-mediated migration of mesenchymal stem cells is a source of intimal hyperplasia. Arterioscler Thromb Vasc Biol 2013 33 1271 1279. doi: 10.1161/ATVBAHA.112.300773
30. Manka D, Chatterjee TK, Stoll LL, Basford JE, Konaniah ES, Srinivasan R, Bogdanov VY, Tang Y, Blomkalns AL, Hui DY, Weintraub NL, Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1. Arterioscler Thromb Vasc Biol 2014 34 1723 1730. doi: 10.1161/ATVBAHA.114.303983
31. Omar A, Chatterjee TK, Tang Y, Hui DY, Weintraub NL, Proinflammatory phenotype of perivascular adipocytes. Arterioscler Thromb Vasc Biol 2014 34 1631 1636. doi: 10.1161/ATVBAHA.114.303030
32. Rocha VZ, Folco EJ, Ozdemir C, Sheikine Y, Christen T, Sukhova GK, Tang EH, Bittencourt MS, Santos RD, Luster AD, Cohen DE, Libby P, CXCR3 controls T-cell accumulation in fat inflammation. Arterioscler Thromb Vasc Biol 2014 34 1374 1381. doi: 10.1161/ATVBAHA.113.303133
33. Bodnar RJ, Yates CC, Rodgers ME, Du X, Wells A, IP-10 induces dissociation of newly formed blood vessels. J Cell Sci 2009 122 pt 12 2064 2077. doi: 10.1242/jcs.048793
34. Yates CC, Krishna P, Whaley D, Bodnar R, Turner T, Wells A, Lack of CXC chemokine receptor 3 signaling leads to hypertrophic and hypercellular scarring. Am J Pathol 2010 176 1743 1755. doi: 10.2353/ajpath.2010.090564
35. Bodnar RJ, Rodgers ME, Chen WC, Wells A, Pericyte regulation of vascular remodeling through the CXC receptor 3. Arterioscler Thromb Vasc Biol 2013 33 2818 2829. doi: 10.1161/ATVBAHA.113.302012
36. van den Borne P, Haverslag RT, Brandt MM, Cheng C, Duckers HJ, Quax PH, Hoefer IE, Pasterkamp G, de Kleijn DP, Absence of chemokine (C-x-C motif) ligand 10 diminishes perfusion recovery after local arterial occlusion in mice. Arterioscler Thromb Vasc Biol 2014 34 594 602. doi: 10.1161/ATVBAHA.113.303050
37. Waeckel L, Mallat Z, Potteaux S, Combadière C, Clergue M, Duriez M, Bao L, Gerard C, Rollins BJ, Tedgui A, Levy BI, Silvestre JS, Impairment in postischemic neovascularization in mice lacking the CXC chemokine receptor 3. Circ Res 2005 96 576 582. doi: 10.1161/01.RES.0000159389.55544.20
38. Nordon IM, Hinchliffe RJ, Loftus IM, Thompson MM, Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol 2011 8 92 102. doi: 10.1038/nrcardio.2010.180
39. Iida Y, Xu B, Xuan H, Glover KJ, Tanaka H, Hu X, Fujimura N, Wang W, Schultz JR, Turner CR, Dalman RL, Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression. Arterioscler Thromb Vasc Biol 2013 33 718 726. doi: 10.1161/ATVBAHA.112.300329
40. Michineau S, Franck G, Wagner-Ballon O, Dai J, Allaire E, Gervais M, Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects. Arterioscler Thromb Vasc Biol 2014 34 1747 1755. doi: 10.1161/ATVBAHA.114.303913
41. Liehn EA, Tuchscheerer N, Kanzler I, Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 2011 58 2415 2423. doi: 10.1016/j.jacc.2011.08.033